MERANDA RAMEY: Open Payments
NPI 1730577305 · ELKHORN CITY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$967 in 49 payments from 16 companies in 2025. Trend: 2023 $508 · 2024 $662 · 2025 $967
Food & beverage: $967
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $170 |
| Vanda Pharmaceuticals Inc. | 9 | $170 |
| ABBVIE INC. | 5 | $108 |
| Indivior Inc. | 5 | $96 |
| Axsome Therapeutics, Inc. | 5 | $81 |
| Tonix Medicines, Inc. | 2 | $62 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Braeburn Inc. | 2 | $33 |
| Amgen Inc. | 2 | $31 |
Products named: CAPLYTA, HETLIOZ, SUBLOCADE, Auvelity, REXULTI, VRAYLAR, TONMYA, UBRELVY.
Industry payments across KY — which companies pay providers there.
